Cytoplasmic HuR over-expression is associated with increased cyclooxygenase-2 expression in laryngeal squamous cell carcinomas

Pathology

Volumn 39, Issue 6, 2007, Pages 545-550

  Cho, Nam Pyo ^a   Han, Hye Suk ^a   Soh, Yunjo ^a   Lee, Kyung Yeol ^a   Son, Hyun Jin ^a  

^a Chonbuk National University   (South Korea)

Author keywords

Cyclooxygenase 2; HuR; Immunohistochemistry; Laryngeal squamous cell carcinoma; mRNA stability

Indexed keywords

CYCLOOXYGENASE 2; HUR PROTEIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CYTOPLASM; EPITHELIUM DYSPLASIA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNX CARCINOMA; LARYNX MUCOSA; MALE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SQUAMOUS CELL CARCINOMA;

EID: 36249024926     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1080/00313020701684391     Document Type: Article

References (43)

1. Ferlito A, Shaha AR, Silver CE, Rinaldo A, Mondin V. Incidence and sites of distant metastases from head and neck cancer. ORL J Otorhinolaryngol Relat Spec 2001; 63: 202-7.
2. Karamouzis MV, Sotiropoulou-Bonikou G, Vandoros G, et al. Differential expression of retinoic acid receptor beta (RARbeta) and the AP-1 transcription factor in normal, premalignant and malignant human laryngeal tissues. Eur J Cancer 2004; 40: 761-73.
3. Hoffman HT, Karnell LH, Funk GF, et al. The National Cancer Data Base report on cancer of the head and neck. Arch Otolaryngol Head Neck Surg 1998; 124: 951-62.
4. Tabor MP, Brakenhoff RH, Ruijter-Schippers HJ, et al. Multiple head and neck tumours frequently originate from a single preneoplastic lesion. Am J Pathol 2002; 161: 1051-60.
5. Day GL, Blot WJ. Second primary tumors in patients with oral cancer. Cancer 1992; 70: 14-9.
6. Farber E. The multistep nature of cancer development. Cancer Res 1984; 44: 4217-25.
7. Licitra L, Bernier J, Grandi C, et al. Cancer of the larynx. Crit Rev Oncol Hematol 2003; 45: 65-80.
8. Rafferty MA, Fenton JE, Jones AS. An overview of the role and inter-relationship of epidermal growth factor receptor, cyclin D and retinoblastoma protein on the carcinogenesis of squamous cell carcinoma of the larynx. Clin Otolaryngol 2001; 26: 317-20.
9. Sachs AB. Messenger RNA degradation in eukaryotes. Cell 1993; 74: 413-21.
10. Pan YX, Chen H, Kilberg MS. Interaction of RNA-binding proteins HuR and AUF1 with the human ATF3 mRNA 3′-untranslated region regulates its amino acid limitation-induced stabilization. J Biol Chem 2005; 280: 34609-16.
11. Brennan CM, Steitz JA. HuR and mRNA stability. Cell Mol Sci 2001; 58: 266-77.
12. Subbaramaiah K, Marmao TP, Dixon DA, et al. Regulation of cyclooxygenase-2 mRNA stability by taxanes. Evidence for involvement of p38, MAPKAPK-2 and HuR. J Biol Chem 2003; 278: 37637-47.
13. Gantt K, Cherry J, Tenney R, et al. An early event in adipogenesis, the nuclear selection of the CCAAT enhancer-binding protein β (C/EBPβ) mRNA by HuR and its translocation to the cytosol. J Biol Chem 2005; 280: 24768-74.
14. Lu JY, Schneider RJ. Tissue distribution of AU-rich mRNA-binding proteins involved in regulation of mRNA decay. J Biol Chem 2004; 279: 12974-9.
15. Gallouzi IE, Steitz JA. Delineation of mRNA export pathways by the use of cell-permeable peptides. Science 2001; 294: 1895-901.
16. Nabors LB, Gillespie GY, Harkins L, et al. HuR, a RNA stability factor, is expressed in malignant brain tumors and binds to adenine- and uridine-rich elements within the 3′ untranslated regions of cytokine and angiogenic factor mRNAs. Cancer Res 2001; 61: 2154-61.
17. Denkert C, Weichert W, Winzer KJ, et al. Expression of the ELAV-Like protein HuR is associated with higher tumor grade and increased cyclooxygenase-2 expression in human breast carcinoma. Clin Cancer Res 2004; 10: 5580-6.
18. Dixon DA, Tolley ND, King PH, et al. Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells. J Clin Invest 2001; 108: 1657-65.
19. Denkert C, Weichert W, Pest S, et al. Overexpression of the embryonic-lethal abnormal vision-like protein HuR in ovarian carcinoma is a prognostic factor and is associated with increased cyclooxygenase 2 expression. Cancer Res 2004; 64: 189-95.
20. Guhaniyogi J, Brewer G. Regulation of mRNA stability in mammalian cells. Gene 2001; 265: 11-23.
21. Jung TTK, Berlinger NT, Juhn SK. Prostaglandins in squamous cell carcinoma of the head and neck: a preliminary study. Laryngoscope 1985; 95: 307-12.
22. Bennett A, Carroll MA, Stamford IF, et al. Prostaglandins and human lung carcinomas. Br J Cancer 1982; 46: 888-93.
23. Rigas B, Goldman IS, Levine L. Altered eicosanoid levels in human colon cancer. J Lab Clin Med 1993; 122: 518-23.
24. Tsujii M, Kawano S, Tsuji S, et al. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 1998; 93: 705-16.
25. Williams CS, Tsujii M, Reese J, et al. Host cyclooxygenase-2 modulates carcinoma growth. J Clin Invest 2000; 105: 1589-94.
26. Goodwin JS, Ceuppens JL. Regulation of immune response by prostaglandins. J Clin Immunol. 1983; 3, 295-315.
27. Sheng H, Shao J, Marrow JD, et al. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res 1998; 58: 362-6.
28. Schreinemachers DM, Everson RB. Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology 1994; 5: 138-46.
29. Funkhouser EM, Sharp GB. Aspirin and reduced risk of esophageal carcinoma. Cancer 1995; 76: 1116-9.
30. Castonguay A, Rioux N. Inhibition of lung tumorigenesis by sulindac: comparison of two experimental protocols. Carcinogenesis 1997; 18: 491-6.
31. Boolbol SK, Dannenberg AJ, Chadburn A, et al. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res 1996; 56: 2556-60.
32. Erkinheimo TL, Lassus H, Sivula A, et al. Cytoplasmic HuR expression correlates with poor outcome and with cyclooxygenase 2 expression in serous ovarian carcinoma. Cancer Res 2003; 63: 7591-4.
33. Shanmugaratnam K, Sobin LH. The World Health Organization histological classification of tumours of the upper respiratory tract and ear. A commentary on the second edition. Cancer 1993; 71: 2689-97.
34. Heinonen M, Bono P, Narko K, et al. Cytoplasmic HuR expression is a prognostic factor in invasive ductal breast carcinoma. Cancer Res 2005; 65: 2157-61.
35. Lopez de Silanes I, Fan J, Yang X, et al. Role of the RNA-binding protein HuR in colon carcinogenesis. Oncogene 2003; 22: 7146-54.
36. Fan XC, Steitz JA. Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increased the in vivo stability of ARE-containing mRNAs. EMBO J 1998; 17: 3448-60.
37. Wang W, Caldwell MC, Lin S, et al. HuR regulates cyclin A and cyclin B1 mRNA stability during cell proliferation. EMBO J 2000; 19: 2340-50.
38. Wein G, Rossler M, Klug R, et al. The 3′-UTR of the mRNA coding for the major protein kinase C substrate MARCKS contains a novel CU-rich element interacting with the mRNA stabilizing factors HuD and HuR. Eur J Biochem 2003; 270: 350-65.
39. Peng SS, Chen CY, Xu N, et al. RNA stabilization by the AU-rich element binding protein, HuR, an ELAV protein. EMBO J 1998; 17: 3461-70.
40. Tran H, Maurer F, Nagamine Y. Stabilization of urokinase and urokinase receptor mRNAs by HuR is linked to its cytoplasmic accumulation induced by activated mitogen-activated protein kinase-activated protein kinase 2. Mol Cell Biol 2003; 23: 7177-88.
41. Bayazit YA, Buyukberber S, Sari I, et al. Cyclo-oxygenase 2 expression in laryngeal squamous cell carcinoma and its clinical correlates. ORL J Otorhinolaryngol Relat Spec 2004; 66: 65-9.
42. Sun X, Ge R, Dong Q, et al. The expression of cyclooxygenase-2 in laryngeal squamous cell carcinoma and its relationship with MVD. Lin Chuang Er Bi Yan Hou Ke Za Zhi 2005; 19: 967-70.
43. Hur K, Song SH, Lee HS, et al. Aberrant methylation of the specific CpG island portion regulates cyclooxygenase-2 gene expression in human gastric carcinomas. Biochem Biophys Res Commun 2003; 310: 844-51.